China is preparing for large-scale trials and production of the Corona vaccine. According to a Reuters report, the company called Cancino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to conduct large trials of the vaccine abroad.
According to official figures, corona infection in China has reduced very much. But for vaccine trials, volunteers in such areas have to be given vaccine doses where infection is present. In such a situation, China is starting vaccine trials abroad.
Right now the cases of corona in Brazil are increasing rapidly after America. In such a situation, Brazil can be a suitable place for trial of corona vaccine.
CanSino Biologics co-founder Qiu Dongzhu has given information about the plan for the trial abroad. Dongzhu said that Phase-3 trial will start very soon. During this time, preparations are being made to give vaccine dose to 40 thousand people.
CanSino Biologics has developed a corona vaccine named Ad5-nCov. Ad5-nCov is the first vaccine that has been trialled on humans in China.
Also Read: Issue of contractual employees in front of MP Staff Commission / EMPLOYEE NEWS
The company says that during the second phase trial of the Ad5-nCov vaccine, 508 people were given doses, which resulted in very good results.
CanSino Biologics has also said that the company is building a new factory in China. From the beginning of 2021, the vaccine will start production here. In a year, 10 to 20 crore vaccine doses will be prepared from this factory
